Literature DB >> 2440996

Myelin proteolipid protein induces demyelinating disease in mice.

J L Trotter, H B Clark, K G Collins, C L Wegeschiede, J D Scarpellini.   

Abstract

Using two methods of immunization (A and B), 5/10 (A) and 27/45 (B), BALB/c by J mice immunized with human myelin proteolipid protein developed a demyelinating disease with a spectrum of chronic progressive to relapsing-remitting courses. Demyelinative lesions were seen histopathologically in all clinically affected animals that were examined. Many of the clinically unaffected animals also had histopathologic evidence of demyelination. Some of the animals had evidence of multiple ages of foci of activity. Evidence is presented that contamination with myelin basic protein could not account for the disease. This is a new model for multiple sclerosis in mice.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2440996     DOI: 10.1016/0022-510x(87)90271-1

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  15 in total

1.  High cell surface expression of CD4 allows distinction of CD4(+)CD25(+) antigen-specific effector T cells from CD4(+)CD25(+) regulatory T cells in murine experimental autoimmune encephalomyelitis.

Authors:  Jinzhu Li; William Ridgway; C Garrison Fathman; Harley Y Tse; Michael K Shaw
Journal:  J Neuroimmunol       Date:  2007-10-24       Impact factor: 3.478

Review 2.  New insights into the role of mast cells in autoimmunity: evidence for a common mechanism of action?

Authors:  Margaret E Walker; Julianne K Hatfield; Melissa A Brown
Journal:  Biochim Biophys Acta       Date:  2011-02-25

3.  Differential levels of resistance to disease induction and development of relapsing experimental autoimmune encephalomyelitis in two H-2b-restricted mouse strains.

Authors:  Jinzhu Li; Xiaoqing Zhao; Robert Skoff; Michael K Shaw; Harley Y Tse
Journal:  J Neuroimmunol       Date:  2011-04-11       Impact factor: 3.478

4.  Estrogen potentiates treatment with T-cell receptor protein of female mice with experimental encephalomyelitis.

Authors:  H Offner; K Adlard; A Zamora; A A Vandenbark
Journal:  J Clin Invest       Date:  2000-05       Impact factor: 14.808

5.  Experimental allergic encephalomyelitis (EAE) in mice selectively bred to produce high affinity (HA) or low affinity (LA) antibody responses.

Authors:  M E Devey; P J Major; K M Bleasdale-Barr; G P Holland; M C Dal Canto; P Y Paterson
Journal:  Immunology       Date:  1990-04       Impact factor: 7.397

6.  Experimental autoimmune encephalomyelitis in the mouse.

Authors:  Stephen D Miller; William J Karpus
Journal:  Curr Protoc Immunol       Date:  2007-05

Review 7.  Modeling multiple sclerosis in laboratory animals.

Authors:  Bettina Schreiner; Frank L Heppner; Burkhard Becher
Journal:  Semin Immunopathol       Date:  2009-10-03       Impact factor: 9.623

8.  Bone marrow stromal cell therapy reduces proNGF and p75 expression in mice with experimental autoimmune encephalomyelitis.

Authors:  Jing Zhang; Chaya Brodie; Yi Li; Xuguang Zheng; Cynthia Roberts; Mei Lu; Qi Gao; Jade Borneman; Smita Savant-Bhonsale; Stanton B Elias; Michael Chopp
Journal:  J Neurol Sci       Date:  2009-02-03       Impact factor: 3.181

9.  Fine specificity of CD4+ T cell responses to the dominant encephalitogenic PLP 139-151 peptide in SJL/J mice.

Authors:  B L McRae; S D Miller
Journal:  Neurochem Res       Date:  1994-08       Impact factor: 3.996

Review 10.  Peptide determinants of myelin proteolipid protein (PLP) in autoimmune demyelinating disease: a review.

Authors:  V K Tuohy
Journal:  Neurochem Res       Date:  1994-08       Impact factor: 3.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.